Excited to share that the paper from our group entitled: Deficiency of ZC3HC1 modulates vascular smooth muscle cell phenotype and increases neointima formation, has been accepted in ATVB! Stay tuned for the final publication.
We are delighted to announce that our MLS student, Laura Kitzmann, who is currently completing her bachelorโs thesis at our Institute in the research group of Dr. Jorge Enrique Duque Escobar, has been awarded a Young DGK Travel Grant by the Deutsche Gesellschaft fรผr Kardiologie โ Herz- und Kreislaufforschung e.V.
This grant will enable her to attend her first scientific congress, the DGK Annual Meeting, which will take place in Mannheim from April 8โ11, 2026. We are happy to travel with you, Laura! DGK Travel Team: Nadine Odenthal, Dr. Jorge Enrique Duque Escobar, Teng Tong, Olga Schweigert, Tobias Reinberger, Pashmina Wiqar, Amer Ghalawinji, PhD.
We are pleased to share that Tristan Gritzka, MD doctoral student at our Institute, was awarded the ๐๐จ๐ค๐ญ๐จ๐ซ๐๐ง๐๐๐ง๐ฌ๐ญ๐ข๐ฉ๐๐ง๐๐ข๐๐ง ๐๐๐๐ at the Dresdner Herz-Kreislauf-Tage (DHKT), held from January 23โ25, 2026. His doctoral research focuses on the molecular role of PHACTR1 in vascular function and atherosclerosis and is supervised by Prof. Dr. Tanja Zeller and Dr. Olga Schweigert Congratulations to Tristan, and we wish him a successful doctoral journey!
Why do young people without classic risk factors suffer strokes or heart attacks? A new research group funded by the German Research Foundation (DFG) aims to answer this critical question.
The research unit FOR 5930, led by the University of Lรผbeck, brings together scientists from Lรผbeck, Berlin, and Kiel to systematically investigate, for the first time, how misdirected antibodies can trigger inflammation in blood vessels and thereby cause severe vascular diseases. The DFG is funding the four-year project with approximately โฌ6.2 million.
The institute is actively involved in these interdisciplinary research activities through its collaboration with the research group led by Prof. G. Riemekasten. The newly established research group, titled โAutoantibodies Against G ProteinโCoupled Receptors as Drivers of Vascular Diseases (AbsInVasc)โ, focuses on understanding the development of pathogenic autoantibodies that specifically target G proteinโcoupled receptors.
A key component of the research is Project P1, led by PD Dr. Aherrahrou, which examines the role of CXCR3/4 expression and its interaction with autoantibodies in atherosclerosis. By uncovering these molecular mechanisms, the researchers hope to identify new pathways that explain vascular disease in patients without traditional risk profiles and ultimately contribute to improved diagnostic and therapeutic strategies.
Lรผbeck live: Forschungsgruppe untersucht Antikรถrper als Treiber schwerer Gefรครerkrankungenย
On January 20, 2026, the kick-off meeting of the DZHK Scientific Seminar Lรผbeck was successfully held at the University Hospital Schleswig-Holstein (UKSH).
The session opened with welcome remarks by Prof. Dr. Ingo Eitel and Prof. Dr. Tanja Zeller. As part of the program, Dr. Jorge Enrique Duque Escobar from the Institute for Cardiogenetics presented a project from the DZHK Partner Site. The presentation introduced the DZHK Partner Site Project for the funding period 2026โ2030, entitled:
โTargeting Omics-Derived Inflammatory Candidates for Novel Atherosclerosis Therapy.โ
The talk was followed by an active and constructive scientific discussion.
The newly established seminar series aims to strengthen networking between clinical practice and research and to foster translational collaborations. We look forward to contributing to this platform and to continued scientific exchange in the upcoming monthly seminars.
February 17
March 17
April 21
May 19
June 16
July 21
August 18
September 15
October 20
November 17
Im Rahmen des globalen Programms LDL Connect werden fรผhrende Expertinnen und Experten neueste Strategien im Lipidmanagement diskutieren โ mit besonderem Fokus auf die รberwindung von Versorgungslรผcken bei Post-ACS-Hochrisikopatienten.
Unter der Leitung der Co-Chairs Prof. Raul D. Santos (Brasilien) und Prof. Ingo Eitel (Deutschland) erwartet Sie ein interaktives Programm mit aktuellen wissenschaftlichen Erkenntnissen, praxisnahen Erfahrungen und innovativen Tools zur Verbesserung der Patientenversorgung.
Die Veranstaltung findet zeitgleich in Lรผbeck (Deutschland) und Rio de Janeiro (Brasilien) statt. Beide Standorte sind live miteinander verbunden, um gemeinsam globale Strategien fรผr eine optimierte Versorgung zu entwickeln.
14.10.2025, 12:30 Uhr, Universitรคres Herzzentrum Lรผbeck im Besprechungsraum Langeoog 1/2ย
Die Teilnahme ist kostenfrei. Anmeldung unter: https://webapp.spotme.com/login/eventspace/LDL-C_connect_webinarย
Erkenntnisse aus der Forschung in die Praxis zu bringen, ist ein komplexer mehrstufiger Prozess. Das DZG-Trainingsprogramm “Beyond the bench – Turning discoveries into treatments” richtet sich an junge Wissenschaftler aller DZGs, die sich fรผr translationale Forschung interessieren.
Nรคchster Termin:
02.07.2025, 13-14:45 Uhr, online via zoom
3. Workshop: Potential partners on the way through the translational pipeline
Registration: https://eu01web.zoom.us/meeting/register/kzsnPZ-gTtG2SJuRI89JiAย
We are very much looking forward to the 14th DZHK Retreat North (formerly NCCR), taking place on June 19โ20 at the Hotel Atlantik Lรผbeck.
As every year, the retreat offers an excellent opportunity for scientific exchange, networking, and the presentation of current research projects within the DZHK Northern partner sites.
Participants can look forward to an inspiring program with talks, poster sessions, and discussions in a collegial atmosphere.
Weโre excited to welcome you in Lรผbeck!
Front Cell Dev Biol. 2023 Apr 11;11:1143852. doi: 10.3389/fcell.2023.1143852.
Hoffmann J, Hanร S, Kraus M, Schaller J, Schรคfer C, Stahl D, Anker SD, Anton G, Bahls T, Blankenberg S, Blumentritt A, Boldt LH, Cordes S, Desch S, Doehner W, Dรถrr M, Edelmann F, Eitel I, Endres M, Engelhardt S,ย Erdmann J, Eulenburg K, Falk V, Felix SB, Frank D, Franke T, Frey N, Friede T, Geidel L, Germans L, Grabmaier U, Halle M, Hausleiter J, Jakobi V, Jebran AF, Jobs A, Kรครคb S, Karakas M, Katus HA, Klatt A, Knosalla C, Krebser J, Landmesser U, Lee M, Lehnert K, Lesser S, Leyh K, Lorbeer R, Mach-Kolb S, Meder B, Nagel E, Nolte CH, Parwani AS, Petersmann A, Puls M, Rau H, Reiser M, Rienhoff O, Scharfe T, Schattschneider M, Scheel H, Schnabel RB, Schuster A, Schmitt B, Seidler T, Seiffert M, Stรคhli BE, Stas A, J Stocker T, von Stรผlpnagel L, Thiele H, Wachter R, Wakili R, Weis T, Weitmann K, Wichmann HE, Wild P, Zeller T, Hoffmann W, Zeisberg EM, Zimmermann WH, Krefting D, Kรผhne T, Peters A, Hasenfuร G, Massberg S, Sommer T, Dimmeler S, Eschenhagen T, Nauck M.
Clin Res Cardiol. 2023 Mar 8. doi: 10.1007/s00392-023-02177-5.
